Condition: Leukemia, Myeloid, Acute · Sponsor: Guangzhou Bio-gene Technology Co., Ltd
This is a single-arm, single-dose dose-escalation and dose-expansion study.
This description comes directly from the study's public registry record.
Min Luo, Doctorate · +86 020 32030437 · mluo@gzbiogene.com
Always discuss trial participation with your own doctor first.
| ZhuJiang Hospital of Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
| Nanfang Hospital of Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06118788